Oncology Drug Reference Sheet: Decitabine and Cedazuridine
Kristine B. LeFebvre DNP, RN, NPD-BC, AOCN®
Voice
Description
In July 2020, the U.S. Food and Drug Administration approved decitabine and cedazuridine (Inqovi®) tablets for the treatment of adults with myelodysplastic syndromes (MDS).
ONS Drug Education
Short summaries of newly approved oncology-related therapies or drugs with new indications.
View All Drug Education